GOCO - GoHealth Inc.
GoHealth Inc. Logo

GOCO - GoHealth Inc.

https://www.gohealth.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results - GoHealth ( NASDAQ:GOCO )
Benzinga • 1 month, 1 week ago • score: 0.26
CHICAGO, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- GoHealth, Inc. ( GoHealth ) GOCO, a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial ...
Neutral
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. ( NASDAQ: GOCO ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GoHealth ( NASDAQ:GOCO )
Benzinga • 2 months ago • score: -0.05
NEW YORK, July 10, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. GOCO resulting from allegations that GoHealth may have issued materially misleading business ...
Neutral
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm - Fulgent Genetics ( NASDAQ:FLGT ) , Abacus Global Management ( NASDAQ:ABL )
Benzinga • 2 months, 2 weeks ago • score: -0.09
NEW YORK, June 30, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. GOCO, Semler Scientific Inc. SMLR, Fulgent Genetics, Inc. FLGT, and Abacus Global Management, Inc.
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-09 (Snapshot)

GoHealth, Inc. is a health insurance marketplace and a Medicare-focused digital health company in the United States. The company is headquartered in Chicago, Illinois.

52W High
$21.00
52W Low
$4.72
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.61
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
555.56
EV/EBITDA (<8 favorable)
5.48
EV/Revenue (<3 favorable)
0.84
P/S (TTM) (<3 favorable)
0.17
P/B (<3 favorable)
0.40
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
15.64%
Institutions (25–75% balanced)
60.62%
Shares Outstanding
15,988,400
Float
9,490,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
822,444,000
Gross Profit (TTM)
678,843,000
EPS (TTM)
-2.62
Profit Margin (>10% good)
-0.03%
Operating Margin (TTM) (higher better)
-0.49%
ROE (TTM) (>15% strong)
-0.15%
EPS YoY (Quarterly) (>10% good)
4.24
Revenue YoY (Quarterly) (>8% good)
-0.11
Momentum
Bearish momentum
Value
-0.2872
Previous
-0.3164
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025